Product Name Rhapontigenin
CAS No.: 500-65-2
Catalog No.: CFN92607
Molecular Formula: C15H14O4
Molecular Weight: 258.3 g/mol
Purity: >=98%
Type of Compound: Phenols
Physical Desc.: Cryst.
Targets: ROS | PAK | p21 | PI3K | Akt | Tyrosinase | HIF | VEGFR | Antifection
Source: The rhizomes of Rheum undulatum.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $178/20mg
Rhapontigenin has antioxidative, antihyperlipidemic, antifungal and anticancer activities. Rhapontigenin inhibits HIF-1α accumulation and angiogenesis in PC-3 prostate cancer cells, suppresses breast cancer cell migration and invasion, which is involved in inhibiting the PI3K-dependent Rac1 signaling pathway. Rhapontigenin exhibits dose-dependent inhibition of tyrosinase activity and melanin synthesis in B16F10 melanoma cells.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Molecules.2015, 20(10):19172-88
  • Int J Mol Sci.2019, 20(9):E2244
  • Universite de Bordeaux2017, 2017BORD0867
  • Chinese Medicine2019, 14(1)
  • Integr Cancer Ther.2018, 17(3):832-843
  • Molecules.2019, 24(21):E3834
  • Front Immunol.2017, 8:1542
  • Molecules.2019, 25(1):E103
  • Phytomedicine.2018, 41:62-66
  • Cancer Manag Res.2019, 11:483-500
  • Salvianolic acid F

    Catalog No: CFN90811
    CAS No: 158732-59-3
    Price: $596/10mg

    Catalog No: CFN92426
    CAS No: 32507-66-7
    Price: $218/20mg

    Catalog No: CFN97824
    CAS No: 139101-67-0
    Price: Inquiry(manager@chemfaces.com)

    Catalog No: CFN92607
    CAS No: 500-65-2
    Price: $178/20mg

    Catalog No: CFN98569
    CAS No: 155-58-8
    Price: $60/20mg
    Rhapontigenin 3'-O-glucoside

    Catalog No: CFN90749
    CAS No: 94356-22-6
    Price: $358/10mg
    Piceatannol 3'-O-glucoside

    Catalog No: CFN90750
    CAS No: 94356-26-0
    Price: $308/10mg

    Catalog No: CFN92486
    CAS No: 29884-49-9
    Price: Inquiry(manager@chemfaces.com)

    Catalog No: CFN90204
    CAS No: 95041-90-0
    Price: $118/20mg

    Catalog No: CFN98368
    CAS No: 29700-22-9
    Price: $50/20mg
    Planta Med. 2014 Aug;80(13):1067-71.
    Antihyperlipidemic effects of rhapontin and rhapontigenin from rheum undulatum in rats fed a high-cholesterol diet.[Pubmed: 25127020]
    Rhapontin was purified from a methanol extract from the roots of Rheum undulatum, and Rhapontigenin was produced by an enzymatic transformation of rhapontin. Rats were fed a high-cholesterol diet to induce hyperlipidemia, followed by oral treatment with rhapontin or Rhapontigenin (1-5 mg/kg/day). Rhapontin and Rhapontigenin treatment resulted in a significant (p<0.05) dose-dependent decrease in the serum lipid level, while the high-density lipoprotein cholesterol level increased slightly compared with the experimental control. Furthermore, rhapontin and Rhapontigenin treatment improved the pathological characteristics of the degenerating fatty liver in high-cholesterol diet-induced hyperlipidemic rats dose-dependently. Aspartate aminotransferase and alanine aminotransferase levels in rhapontin- and Rhapontigenin-treated hyperlipidemic rats were not significantly different from those in the control. These results indicate that rhapontin and Rhapontigenin can be used as potent antihyperlipidemic agents.
    Med Mycol. 2013 Jan;51(1):45-52.
    The possible mechanism of rhapontigenin influencing antifungal activity on Candida albicans.[Pubmed: 22662760]
    Rhapontigenin, an aglycone of rhapontin, was produced by biotransformation and we investigated its antifungal activity against Candida albicans, one of the most important opportunistic fungal pathogens. Rhapontigenin is found to have, in vitro, inhibitory activity with a minimal inhibitory concentration (MIC) value against all test isolates of 128-256 μg/ml. We detected increased reactive oxygen species (ROS) levels in yeast cultures treated with Rhapontigenin at the MIC. Rhapontigenin inhibited DNA, RNA, and protein synthesis, especially RNA synthesis, and induced morphological changes and apoptosis of C. albicans. The apoptotic effect of Rhapontigenin on C. albicans at subinhibitory concentrations was higher in the stationary growth phase than in the exponential phase, while the opposite results were noted with amphotericin B. The mechanism of antifungal activity of Rhapontigenin may be associated with the generation of ROS that might induce apoptosis and it may also involve the inhibition of ergosterol biosynthesis.
    J Nat Prod. 2014 May 23;77(5):1135-9.
    Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells.[Pubmed: 24828286]
    Rhapontigenin (1) has various biological activities including anticancer activities. However, whether and how Rhapontigenin affects cancer invasion has never been explored. Here, we examined the anti-invasive effects of Rhapontigenin and its underlying molecular mechanisms in the highly invasive human breast cancer cell line designated MDA-MB-231. At noncytotoxic concentrations, Rhapontigenin strongly suppressed serum-induced cell migration and invasion as judged by Boyden chamber analysis and wound-healing assays, respectively. Rhapontigenin strikingly reduced Rac1 activity as judged by both absorbance-based and pull-down assays. In addition, its downstream effectors such as WASP-family verprolin homologous proteins 2 (WAVE-2) and p21-activated kinase Rhapontigenin (PAK1) signaling cascades were attenuated after treatment with Rhapontigenin. Immunofluorescence staining showed that Rhapontigenin diminished lamellipodia formation at the leading edge of cells. Finally, Rhapontigenin decreased the phosphorylation of phosphoinisitide-3-kinase (PI3K) and AKT. Rac1 activity was inhibited by the PI3K inhibitor wortmannin. Taken together, these results suggest that Rhapontigenin suppresses breast cancer cell migration and invasion, which is involved in inhibiting the PI3K-dependent Rac1 signaling pathway.
    Biosci Biotechnol Biochem. 2012;76(12):2307-9.
    Rhapontigenin converted from rhapontin purified from Rheum undulatum enhances the inhibition of melanin synthesis.[Pubmed: 23221688]
    Rhapontigenin was produced from rhapontin isolated from a methanol extract of Rheum undulatum roots by enzymatic transformation. Rhapontin and Rhapontigenin exhibited dose-dependent inhibition of tyrosinase activity and melanin synthesis in B16F10 melanoma cells, but the inhibitory activity of Rhapontigenin was greater than that of rhapontin. Thus the bioconversion of rhapontin enhanced its ability to inhibit cellular tyrosinase activity and melanin synthesis.
    Biol Pharm Bull. 2011;34(6):850-5.
    Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.[Pubmed: 21628883]
    The inhibitory mechanism of Rhapontigenin isolated from Vitis coignetiae was investigated on HIF-1α stability and angiogenesis in human prostate cancer PC-3 cells. Rhapontigenin significantly suppressed HIF-1α accumulation at protein level but not at mRNA level in PC-3 cells under hypoxia. Also, Rhapontigenin suppressed hypoxia-induced HIF-1α activation in various cancer cells, such as colorectal adenocarcinoma (SW620), breast adenocarcinoma (MCF-7), fibrosarcoma (HT-1080) and prostate carcinoma (LNCaP). Interestingly, Rhapontigenin had more potency in inhibition of hypoxia-induced HIF-1α expression than that of resveratrol, a known HIF-1α inhibitor. In addition, Rhapontigenin promoted hypoxia-induced HIF-1α degradation and cycloheximide (CHX) blocked protein synthesis. A prolyl hydroxylase (PHD) inhibitor dimethyloxalylglycine (DMOG) is usually utilized to examine whether prolyl hydroxylation is involved in inhibition of HIF-1α accumulation. Here, DMOG recovered HIF-1α accumulation inhibited by Rhapontigenin. Immunoprecipitation assay also revealed that rhapotigenin enhanced the binding of hydroxylated HIF-1α to von Hippel-Lindau (VHL) tumor suppressor protein. Furthermore, Rhapontigenin reduced vascular endothelial growth factor (VEGF) secretion in hypoxic PC-3 cells as well as suppressed tube formation in human umbilical vein endothelial cells (HUVECs) treated by the conditioned media of hypoxic PC-3 cells. However, anti-angiogenic effect of Rhapontigenin in hypoxic PC-3 cells was reversed by DMOG. Taken together, these findings suggest that Rhapontigenin inhibits HIF-1α accumulation and angiogenesis in PC-3 prostate cancer cells.

    Catalog No: CFN98531
    CAS No: 27210-57-7
    Price: $288/5mg

    Catalog No: CFN98887
    CAS No: 531-44-2
    Price: $168/20mg
    Neochlorogenic acid

    Catalog No: CFN97472
    CAS No: 906-33-2
    Price: $138/20mg

    Catalog No: CFN90839
    CAS No: 52250-35-8
    Price: $218/10mg

    Catalog No: CFN95077
    CAS No: 49776-79-6
    Price: $413/5mg
    6''-O-acetylsaikosaponin A

    Catalog No: CFN95086
    CAS No: 64340-46-1
    Price: $268/10mg

    Catalog No: CFN95092
    CAS No: 83151-90-0
    Price: $398/5mg

    Catalog No: CFN95122
    CAS No: 69393-95-9
    Price: $398/5mg
    Astin B

    Catalog No: CFN95188
    CAS No: 151201-76-2
    Price: $318/10mg
    Stevioside D

    Catalog No: CFN95230
    CAS No: 1310055-59-4
    Price: $463/5mg